Phase 2 Study of DKN-01 in Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cynthia Sirard
Leap Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitaetsklinikum Hamburg-Eppendorf (uke) - Universitaeres Cancer Center Hamburg (ucch)
Hamburg, Germany
- Universitaetsklinikum Heidelberg (ukhd) - Nationales Centrum Fuer Tumorerkrankungen Heidelberg (nct)
Heidelberg, Germany
- Slk-Kliniken Heilbronn Gmbh - Klinikum Am Gesundbrunnen - Klinik Fuer Innere Medizin Iii
Heilbronn, Germany
- Gemeinschaftspraxis Fuer Haematologie Und Onkologie - Magdeburg
Magdeburg, Germany
- Universitaetsmedizin Der Johannes Gutenberg-Universitaet Mainz
Mainz, Germany
- Dong-A University Medical Center
Busan, South Korea
- Kyungpook National University Chilgok Hospital
Daegu, South Korea
- Gachon University Gil Medical Center
Incheon, South Korea
- Inha University Hospital
Incheon, South Korea
- Cha University - Bundang Cha General Hospital
Seongnam-si, South Korea
- Seoul National University Bundang Hospital
Seongnam-si, South Korea
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- the Catholic University of Korea - St. Vincent'S Hospital
Suwon, South Korea
- the University of Arizona Cancer Center
Tucson, Arizona, United States
- Ucla
Los Angeles, California, United States
- Florida Cancer Specialists & Research Institute (fcs)
Cape Coral, Florida, United States
- Florida Cancer Specialists & Research Institute
Fleming Island, Florida, United States
- Florida Cancer Specialists & Research Institute
Gainesville, Florida, United States
- Miami Cancer Institute
Miami, Florida, United States
- Florida Cancer Specialists & Research Institute
Wellington, Florida, United States
- Hematology Oncology Clinic
Baton Rouge, Louisiana, United States
- Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
- Oncology Hematology Associates - Springfield
Springfield, Missouri, United States
- Northwell Health
Lake Success, New York, United States
- Cornell University
New York, New York, United States
- Mount Sinai Medical Center - New York
New York, New York, United States
- New York University
New York, New York, United States
- White Plains Hospital
White Plains, New York, United States
- Messino Cancer Centers
Asheville, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Prisma Health Cancer Institute - Faris
Greenville, South Carolina, United States
- Sanford Cancer Center
Sioux Falls, South Dakota, United States
- Tennessee Oncology
Chattanooga, Tennessee, United States
- Scri Oncology Partners
Nashville, Tennessee, United States
- Tennessee Oncology
Nashville, Tennessee, United States
- Multicare Tacoma General Hospital
Tacoma, Washington, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Aug 2022
- Primary completion
- 10 Jul 2025
- Completion
- 10 Jul 2025
- Last update posted
- 3 Aug 2025
- Registered enrollment
- 188
- Registry id
- NCT05480306
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.